07.01.2019
opracowała: lek. Martyna Biała
Na podstawie: Liew Z., Hill A., Simmons B.: Dual therapy with PI/r+3TC or PI/r+TDF shows non-inferior HIV RNA suppression and lower rates of discontinuation for adverse events, versus triple therapy. Meta-analysis of seven randomised trials in 1624 patients.
Journal of the International AIDS Society, Abstract Supplement, HIV Glasgow, 28-31.10.2018; O144